Industry News

Your Current Position: News and Trends > Industry News

06

2020-05

【Industry News】 The CDE issued a notice to solicit public opinion on the 《Guideline on the Submission of Clinical Trial Data》

2020-05-06，The CDE issued a notice to solicit public opinion on the 《Guideline on the Submission of Clinical Trial Data》.
30

2020-04

【Industry News】 The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)

2020-04-30，The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)
30

2020-04

【Industry News】 The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》

2020-04-30，The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》。
30

2020-04

【Industry News】 The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》

The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》
30

2020-04

【Industry News】 The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》

The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》
30

2020-04

【Industry News】 TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》

TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》
29

2020-04

【Industry News】 The NMPA issued a notice to solicit public opinion on seven documents , including《Registration Classification and Requirements for Application Materials of Biological Products (Draft for public review)》

The NMPA issued a notice to solicit public opinion on seven documents , including《Registration Classification and Requirements for Application Materials of Biological Products (Draft for public review)》
29

2020-04

【Industry News】 The NMPA issued a notice to solicit public opinion on several documents , including《Registration Classification and Requirements for Application Materials of Chemicals (Draft for public review)》

The NMPA issued a notice to solicit public opinion on several documents , including《Registration Classification and Requirements for Application Materials of Chemicals (Draft for public review)》
29

2020-04

【Industry News】 The NMPA issued a notice to solicit public opinion on six documents , including《Special Provisions on Registration Administration of Traditional Chinese Medicine (Draft for public review)》

The NMPA issued a notice to solicit public opinion on six documents , including《Special Provisions on Registration Administration of Traditional Chinese Medicine (Draft for public review)》
26

2020-04

【Industry News】 The NMPA and National Health Commission of the PRC issued the announcement about the quality management standard for drug clinical trials (No. 57 of 2020)

The NMPA and National Health Commission of the PRC issued the announcement about the quality management standard for drug clinical trials (No. 57 of 2020)